Amgen(NASDAQ:AMGN) will present at the 8th annual Evercore ISI HealthCONx Conference at 10:00 a.m. ETonDecember 3, 2025.Peter Griffith, executive vice president and chief financial officer atAmgen, and Jay Bradner, executive vice president of Research and Development atAmgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments inAmgen's business given by management at certain investor and medical conferences, can be found onAmgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

AboutAmgen

Amgendiscovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago,Amgenhelped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today.Amgenis advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.

In 2024,Amgenwas named one of the "World's Most Innovative Companies" byFast Companyand one of "America's Best Large Employers" by Forbes, among otherexternal recognitions.Amgenis one of the 30 companies that comprise the Dow Jones Industrial Average(R), and it is also part of the Nasdaq-100 Index(R), which includes the largest and most innovative non-financial companies listed on theNasdaq Stock Marketbased on market capitalization.

For more information, visitAmgen.com and follow us on X (formerly known as Twitter), LinkedIn, Instagram, YouTube and Threads.

CONTACT: Amgen, Thousand OaksElissa Snook, 609-251-1407 (media)Casey Capparelli, 805-447-1746 (investors)

https://mma.prnewswire.com/media/213782/AMGEN_LOGO_V1.jpg

https://edge.prnewswire.com/c/img/favicon.png?sn=LA31321&sd=2025-11-24

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-8th-annual-evercore-isi-healthconx-conference-302623651.html

SOURCE Amgen

https://rt.newswire.ca/rt.gif?NewsItemId=LA31321&Transmission_Id=202511241600PR_NEWS_USPR_____LA31321&DateId=20251124

COMTEX_470515563/1005/2025-11-24T16:00:34